Christina Cheddar Berk

2 months ago | cnbc.com | Christina Cheddar Berk

As investors try to find their footing after recent bouts of hyper-volatile trading, portfolio manager Dan Niles is cautioning patience. "You can't fix all your positioning problems in one day," the founder and portfolio manager at Niles Investment Management told CNBC's "Closing Bell Overtime" on Wednesday.

2 months ago | cnbc.com | Christina Cheddar Berk

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's goal of bringing manufacturing back to the United States has put the industry in the administration's crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated the idea and hinted that details would arrive in early April.

Mar 11, 2025 | cnbc.com | Christina Cheddar Berk

Despite escalating trade tensions between Canada and the United States, oil and energy will continue to flow across the border, said Enbridge CEO Greg Ebel. As the chief of a Calgary-based operator of oil and gas pipelines that cross the U.S.'s northern border, Ebel has been watching the evolving trade policy closely, and is hopeful the two sides will reach a resolution.

Mar 10, 2025 | cnbc.com | Christina Cheddar Berk

There are lots of reasons to be excited about natural gas, according to the CEO of EQT Corp., the largest pure-play producer of the commodity in the U.S. "The market is screaming that we need more energy in this world," EQT president and CEO Toby Rice told CNBC's Brian Sullivan in an interview at the CERAWeek by S & P Global energy conference in Houston.

Feb 5, 2025 | cnbc.com | Christina Cheddar Berk

Investors are hoping to hit the reset button with Eli Lilly 's earnings report on Thursday morning. In mid-January, the maker of obesity medication Zepbound lowered its fourth-quarter revenue forecast as sales of the GLP-1 drug ramped up slower than anticipated. The warning followed disappointing third-quarter results in October, which led to months of choppy stock performance. Shares are trying to regain momentum, with a 9% advance since the year began.